vcvibes

Treo Ventures, LLC

Emerging manager

SEC exempt reporting adviser (venture capital exemption).

HQ
NV

Treo Ventures, LLC focuses on medical device and digital health innovation that can significantly impact human life, investing in companies based in the US and Europe. Its General Partners are Mudit K. Jain, PhD, Brad H. Vale, PhD, DVM, and Tracy Pappas, and Dave Shanahan, BSc is a Venture Partner. Portfolio companies include ShiraTronics, Avivomed, SecondWave Systems, iVEAcare, InterVene, Noctrix Health, Neuspera Medical, NuXcel, Hyalex, and NeoChord.

New fund likely raising soon

The firm's newest fund is 4 to 7 years past its first sale and no newer Form D has been filed.

01 · Says / Does

TagSaysDoes
StagesNot statedNot enough dated deals
SectorsDigital health, Medical devicesNot enough dated deals
RegionsGlobalNot enough dated deals

Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.

02 · Fund history

FundYearSizeStatus
Treo Ventures II, L.P.

Treo Ventures focuses on medical device and digital health innovation that can significantly impact human life, targeting large unmet clinical needs. It invests in companies based in the US and Europe, including neuromodulation and medtech startups. Inferred from the firm's website and portfolio companies

approx. 2022$150M (Form D)Late investment period

03 · People across funds

04 · Recent deals

No dated deals found yet.

05 · Latest from the firm

No news from the firm's website yet.

06 · Sources

  1. http://www.treovp.com
  2. https://treovp.com/contact-us/
  3. https://treovp.com/
  4. https://treovp.com/our-team/

Fund dates and sizes are from SEC Form D filings.

Last verified: Oct 28, 2026